Rosuvastatin-acenocoumarol interaction

Clin Ther. 2005 Jun;27(6):782-4. doi: 10.1016/j.clinthera.2005.06.007.

Abstract

Background: Previous evidence suggests that hydroxymethylglutaryl coenzyme A-reductase inhibitors (statins) might potentiate the effect of oral anticoagulants, but a MEDLINE search (key terms: stains, rosuvastatin, anticoagulants, acenocoumarol, and interaction; years: 1980-2005) revealed no reports of an interaction between rosuvastatin and acenocoumarol.

Objective: The aim of this article was to describe a case of possible interaction between rosuvastatin and acenocoumarol.

Methods: We report the case of a 36-year-old male patient receiving long-term oral treatment with acenocoumarol, a synthetic coumarin anticoagulant, who experienced an increase in international normalized ratio (INR) and a hematoma in the left leg approximately 45 days after the initiation of treatment with rosuvastatin.

Results: After discontinuation of both drugs, an unexpectedly rapid decrease in INR was observed.

Conclusions: Based on the results of this case, a possible pharmacologic interaction between rosuvastatin and acenocoumarol should be considered. Rosuvastatin might enhance the anticoagulant effect of acenocoumarol, and a rebound effect in cases of simultaneous discontinuation of both drugs might occur. Rosuvastatin should be administered with extreme caution in patients receiving long-term acenocoumarol therapy.

Publication types

  • Case Reports

MeSH terms

  • Acenocoumarol / administration & dosage
  • Acenocoumarol / adverse effects*
  • Acenocoumarol / therapeutic use
  • Administration, Oral
  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Drug Interactions
  • Drug Therapy, Combination
  • Fluorobenzenes / administration & dosage
  • Fluorobenzenes / adverse effects*
  • Fluorobenzenes / therapeutic use
  • Hematoma / chemically induced
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • International Normalized Ratio
  • Leg
  • Male
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Rosuvastatin Calcium
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium
  • Acenocoumarol